Journal of Endoluminal Endourology https://jeleu.com/index.php/JELEU <p>The Journal of Endoluminal Endourology is a new urological journal which focuses on publishing articles focusing on the growing sector of endoscopic endoluminal surgery of the genito-urinary tract. A wide range of areas are covered including paediatric and adult surgery, in addition to benign and malignant disease. The endoluminal endescopic management of stricture disease, benign prostate enlargement,</p> The Dougmar Publishing Group Inc., en-US Journal of Endoluminal Endourology 2561-9187 <p align="justify"><span style="color: rgba(0,0,0,0.870588); font-family: 'Noto Sans',-apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Oxygen-Sans,Ubuntu,Cantarell,'Helvetica Neue',sans-serif; font-size: 14px; background-color: #ffffff;">Copyright of articles published in all DPG titles is retained by the author(s). The author(s) grants DPG the rights to publish the article and identify itself as the original publisher. The author grants DPG exclusive commercial rights to the article. <span style="text-align: justify; color: rgba(0,0,0,0.870588); font-family: 'Noto Sans',-apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Oxygen-Sans,Ubuntu,Cantarell,'Helvetica Neue',sans-serif; font-size: 14px; background-color: #ffffff;">The author grants any party the rights to use the article freely for non-commercial purposes provided that the original work is properly cited.</span></span></p> Post-operative Events with Post-operative Day One Stent Removal after Percutaneous Nephrolithotomy https://jeleu.com/index.php/JELEU/article/view/159 <p style="font-weight: 400;"><strong>Introduction:</strong> Percutaneous nephrolithotomy (PCNL) is the gold standard for treating large or complex renal stones. Renal drainage after the procedure is most commonly via nephrostomy tube or indwelling ureteral stent, but the optimal duration of ureteral stents after PCNL is currently unknown. This study describes the post-operative events occurring with early stent removal on post-operative day one (POD1) in patients undergoing uncomplicated PCNL.</p> <p style="font-weight: 400;"><strong>&nbsp;</strong></p> <p style="font-weight: 400;"><strong>Methods:</strong> We identified 336 patients from a single institution that underwent PCNL between 1/1/2020 and 6/1/2021. Of these, 106 patients with uncomplicated procedures that met inclusion criteria for early stent removal on POD1 were included. Retrospective chart review was performed to collect demographic information, operative data, and to identify adverse outcomes including additional procedures, patient telephone calls for symptoms, complications and emergency department (ED) visits.</p> <p style="font-weight: 400;"><strong>&nbsp;</strong></p> <p style="font-weight: 400;"><strong>Results:</strong> Mean (SD) patient age was 54 (15.1) years and 56% of patients were morbidly obese (Body Mass Index [BMI] &gt;30). Overall post-operative complication rate was low (18.8%) and limited primarily to Clavien I/II complications with only two Clavien III (1.9%) complications. Telephone calls or electronic messages were received from 37.7% of patients, with 16% requiring a visit to the ED or clinic. The most common reason for an ED visit was flank pain (11.1%).</p> <p style="font-weight: 400;"><strong>&nbsp;</strong></p> <p style="font-weight: 400;"><strong>Conclusions:</strong> Early stent removal on POD1 may lead to pain-related telephone calls but appears to be a generally safe and effective management option in carefully selected patients undergoing uncomplicated PCNL.</p> John Patrick Mershon Taylor Goodstein Aliza Khuhro Mary Charleton Amara Ndumele Chase Arnold Tasha Posid Colin Kleinguetl Bodo Knudsen Michael Sourial Copyright (c) 2023 John Patrick Mershon, Taylor Goodstein, Aliza Khuhro, Mary Charleton, Amara Ndumele, Chase Arnold, Tasha Posid, Colin Kleinguetl, Bodo Knudsen, Michael Sourial http://creativecommons.org/licenses/by-nc/4.0 2023-04-25 2023-04-25 6 2 e1 e7 10.22374/jeleu.v6i2.159